# Matt Trudeau

人気のポッドキャストエピソード
更新しました:

#86 Stability vs. Support: How Do We Know What Runners Need? (ft. Dr. Matt Trudeau from Brooks Running)

Nate, DJ, and Matt are joined today by a very special guest, Dr. Matt Trudeau of Brooks Running. Matt gives us insights into shoe research and development at Brooks. He also explains Brooks' unique take on stability, support, and how to find the right shoe for your unique running style. Dr. Matt T…

The Truth About Institutional Crypto Adoption | Matthew Trudeau, Chief Operating Officer At ErisX

More and more banks and other financial institutions enter the crypto space. Matt Trudeau, COO at ErisX, a company that provides crypto derivatives to institutional investors, talks about the institutional demand for cryptocurrencies, and potential drivers of crypto adoption, and takes a look at th…

Building Commodity Scale Infrastructure for Carbon Removal—w/ Matt Trudeau, Nori's new CEO

Is buying carbon credits like buying real estate? What would a tradable commodity market for the carbon removal industry look like? In today's episode, Ross sits down with Matt Trudeau, Nori’s new CEO, to get a glimpse of how a veteran market builder thinks about building carbon markets that meet t…

Are carbon credits more like bonds or precious metals?—w/ Tommy Ricketts of BeZero Carbon

Do carbon credit ratings help or harm the growth of carbon markets? How important is standardization to liquidity? Should we look to lessons from the bond market? Equities? Commodities? Derivatives? Precious metals? Real estate?! Get ready to go full high finance — it’s a show about market structur…

115: An Interview With Matt Trudeau of ITF Therapeutics, on Givinostat as a Therapy for Duchenne Muscular Dystrophy

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Matt Trudeau, head of ITF Therapeutics—a division of Italy's Italfarmaco—on treating Duchenne muscular dystrophy with givinostat, a histone deacetylase inhibitor.

Adam Stirling Hour 2 - June 27 - 2023

Continued discussions on Saanich’s proposed People Pets and Parks strategy. Listeners weigh in through calls and texts during open lines.   Rise in e-battery explosions Adam speaks with Matt Trudeau, public information officer for Vancouver Fire and Rescue Services. Vancouver firefighters are n…

Rise in e-battery explosions

  Adam speaks with Matt Trudeau, public information officer for Vancouver Fire and Rescue Services. Vancouver firefighters are now answering more than 50 calls a year to deal with rechargeable batteries exploding. Adam speaks with listeners through calls and texts during open lines.

Rare Disease Commercialization: Beyond Approval

In this episode of The Emerging Biotech Leader, host Kim Kushner sits down with Matt Trudeau, President of ITF Therapeutics, to discuss what it means to operate within a family-run pharmaceutical company and how that model shapes decision-making differently than a public or venture-backed organizat…

From Invisible to Actionable: Unlocking Real-Time Energy Insights in Buildings

Energy is one of the biggest operational costs in buildings, yet it often goes unseen and unmanaged until it’s too late. In this episode of the ASHB Smarter Homes & Buildings Podcast, Shana Longo of Legrand is joined by Matt Trudeau and Shawn Lebrun of Modern Energy Advancements to explore how real…

Can Prediction Markets Become Institutional? - With Rothera's Tom Chippas & Matt Trudeau

JR and Ronan sit down with Tom Chippas and Matt Trudeau of Rothera, a new federally regulated prediction and event markets exchange. Drawing on decades of experience across exchanges, trading, and market structure, they discuss how prediction markets work, how they're regulated, and whether they re…